Marketwide Price Transparency Suggests Significant Opportunities For Value-Based Purchasing.


Journal

Health affairs (Project Hope)
ISSN: 1544-5208
Titre abrégé: Health Aff (Millwood)
Pays: United States
ID NLM: 8303128

Informations de publication

Date de publication:
09 2019
Historique:
entrez: 4 9 2019
pubmed: 4 9 2019
medline: 6 10 2020
Statut: ppublish

Résumé

The extent of price variation across a local market has important implications for value-based purchasing. Using a new data set containing health care prices for nearly every insurer-provider-service triad across a large local market, we comprehensively examined variation in fee-for-service paid commercial prices in Massachusetts for 291 predominantly outpatient medical services. Prices varied considerably across hospital service areas. Prices for medical services at acute hospitals were, on average, 76 percent higher than at all other providers. The service categories with the widest price variation were ambulance/transportation services, physical/occupational therapy, and laboratory/pathology testing. In this market, simulations suggested that steering patients toward lower-price providers or setting price ceilings could generate potential savings of 9.0-12.8 percent. Marketwide price information at the insurer-provider-service level could help target policy interventions to reduce health care spending.

Identifiants

pubmed: 31479358
doi: 10.1377/hlthaff.2018.05315
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1514-1522

Commentaires et corrections

Type : CommentIn

Auteurs

Anna D Sinaiko (AD)

Anna D. Sinaiko ( asinaiko@hsph.harvard.edu ) is an assistant professor of health economics and policy in the Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, in Boston, Massachusetts.

Pragya Kakani (P)

Pragya Kakani is a student in the Harvard PhD program in health policy at Harvard University, in Cambridge, Massachusetts.

Meredith B Rosenthal (MB)

Meredith B. Rosenthal is the C. Boyden Gray Professor of Health Economics and Policy in the Department of Health Policy and Management, Harvard T. H. Chan School of Public Health.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH